Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-07-31
Summary
Patients with SLE have increased rates of atherosclerosis, while the risk factors for atherosclerosis in those patients were not fully revealed. This study is an observational study to investigate the natural process and risk factors for atherosclerosis based on a Chinese SLE cohort. Carotid intima media thickness (CIMT) and brachial-ankle pulse wave velocity (baPWV) will be measured for each patient at baseline and 5-year follow-up. Blood tests including cholesterol levels, fasting plasma glucose levels and etc. will also be performed.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
CIMT and baPWV measurement
All patients will receive carotid intima media thickness (CIMT) and brachial-ankle pulse wave velocity (baPWV) measurement at baseline and 5-year follow-up.
Sponsors & Collaborators
-
Beijing Municipal Science & Technology Commission
collaborator OTHER -
National Natural Science Foundation of China
collaborator OTHER_GOV -
Peking Union Medical College Hospital
lead OTHER
Principal Investigators
-
Shuyang Zhang, MD · Peking Union Medical College Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
NCT06610422 ·Status: NOT_YET_RECRUITING
-
Anti-CD20 Antibodies for Treatment of SLE-PAH
NCT05828147 ·Status: RECRUITING ·Phase: PHASE4
-
A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.
NCT07069972 ·Status: NOT_YET_RECRUITING
-
Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
NCT06287125 ·Status: NOT_YET_RECRUITING
-
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT00985803 ·Status: UNKNOWN ·Phase: PHASE1
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Assessment of Blood Indices in Systemic Lupus Erythematosus
NCT06872086 ·Status: NOT_YET_RECRUITING
-
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
NCT06631404 ·Status: RECRUITING
-
Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus
NCT05262686 ·Status: UNKNOWN ·Phase: PHASE3
-
Anti-infection of Low-does IL-2 in SLE
NCT02932137 ·Status: COMPLETED ·Phase: NA
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
NCT00054938 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Lupus Erythematosus and Accelerated Aging
NCT05698173 ·Status: RECRUITING ·Phase: NA
-
Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study
NCT04431167 ·Status: COMPLETED ·Phase: NA
-
Flow Mediated Dilation in Association With Hyperuricemia
NCT05342285 ·Status: UNKNOWN
-
Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE
NCT02548936 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Insulin Resistance and Atherosclerosis in Women With Lupus
NCT00544102 ·Status: COMPLETED
-
A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
NCT00982670 ·Status: COMPLETED
-
Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis
NCT03958851 ·Status: UNKNOWN
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Dynamic Imaging of Variation in Lupus Nephritis
NCT03180021 ·Status: COMPLETED